Perrigo Company plc

PRGO ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $4.25B $4.37B $4.66B $4.45B $4.14B $4.09B $3.87B $4.73B
Cost of Revenue $2.76B $2.83B $2.98B $3.00B $2.72B $2.59B $2.44B $2.90B
Gross Profit $1.49B $1.54B $1.68B $1.46B $1.42B $1.49B $1.43B $1.83B
Gross Margin 35.1% 35.3% 36.1% 32.7% 34.2% 36.6% 37.0% 38.7%
Operating Expenses
Research & Development $95.4M $112.2M $122.5M $123.1M $122.0M $121.7M $119.2M $218.6M
SG&A Expense $435.9M $468.0M $522.3M $512.3M $482.0M $478.5M $476.5M $435.9M
Operating Income $-1.12B $112.9M $151.9M $78.9M $410.4M $265.2M $174.7M $236.5M
Operating Margin -26.4% 2.6% 3.3% 1.8% 9.9% 6.5% 4.5% 5.0%
Interest Expense
Pretax Income $-1.30B $-80.7M $-8.3M $-139.1M $258.7M $290.6M
Income Tax Expense $104.4M $80.0M $-3.9M $-8.2M $389.6M $-38.3M $-10.7M $159.6M
Net Income $-1.43B $-171.8M $-12.7M $-140.6M $-68.9M $-162.6M $146.1M $131.0M
Net Margin -33.5% -3.9% -0.3% -3.2% -1.7% -4.0% 3.8% 2.8%
EPS (Basic) $-10.29 $-1.25 $-0.09 $-1.04 $-0.52 $-1.20 $1.07 $0.95
EPS (Diluted) $-10.29 $-1.25 $-0.09 $-1.04 $-0.52 $-1.19 $1.07 $0.95
Shares Outstanding (Basic) 138.5M 137.4M 135.3M 134.5M 133.6M 136.1M 136.0M 137.8M
Shares Outstanding (Diluted) 138.5M 137.4M 135.3M 134.5M 133.6M 137.2M 136.5M 138.3M
Dividends Per Share $1.16 $1.10 $1.09 $1.04 $0.96 $0.90 $0.82 $0.76
← Newer Page 1 of 2 Older →